Federated Hermes
FLNA

Federated Hermes’s Filana Therapeutics FLNA Stock Holding History

Federated Hermes’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Buy
115,097
+23,618
+26% +$48.6K ﹤0.01% 1498
2025
Q4 		$181K Buy
91,479
+48,194
+111% +$154K ﹤0.01% 1508
2025
Q3 		$126K Buy
43,285
+5,875
+16% +$13.5K ﹤0.01% 1552
2025
Q2 		$67.7K Hold
37,410
– – ﹤0.01% 1614
2025
Q1 		$56.1K Buy
37,410
+30,310
+427% +$76.5K ﹤0.01% 1627
2024
Q4 		$16.8K Buy
+7,100
New +$125K ﹤0.01% 1786
2022
Q4 		– Sell
-4,160
Closed -$174K – 2265
2022
Q3 		$174K Buy
4,160
+2,633
+172% +$71.1K ﹤0.01% 1545
2022
Q2 		$43K Buy
+1,527
New +$38.6K ﹤0.01% 1686
2021
Q3 		– Sell
-75
Closed -$6K – 2300
2021
Q2 		$6K Sell
75
-58
-44% -$3.11K ﹤0.01% 2024
2021
Q1 		$6K Buy
+133
New +$5.23K ﹤0.01% 2052
2017
Q2 		– Sell
-148
Closed -$1K – 2176
2017
Q1 		$1K Hold
148
– – ﹤0.01% 2091
2016
Q4 		$1K Hold
148
– – ﹤0.01% 2065
2016
Q3 		$1K Buy
+148
New +$2.45K ﹤0.01% 2077
2014
Q3 		– Sell
-193
Closed -$8K – 2052
2014
Q2 		$8K Buy
+193
New +$7.14K ﹤0.01% 1762

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Federated Hermes's FLNA Position: Q1 2026 in Review

Federated Hermes increased its Filana Therapeutics (FLNA) stake by 26% in Q1 2026, buying an estimated $48.6K and bringing the position to 115,097 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Federated Hermes first reported a position in FLNA in Q2 2014 and has held it in 14 quarters since. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Federated Hermes held 115,097 shares of Filana Therapeutics worth $195K as of Q1 2026.
  • Federated Hermes bought 23,618 Filana Therapeutics shares in Q1 2026, an estimated $48.6K.
  • Filana Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1498 holding.
  • Federated Hermes first reported a position in Filana Therapeutics in Q2 2014 and has held it in 14 quarters since.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.